openPR Logo
Press release

Mordor Intelligence, LLP. Contributes to the Diabetes Awareness Month by Granting Free Access to Their Real-Time Exhaustive Research on Diabetes Care Drugs

11-20-2018 09:10 AM CET | Health & Medicine

Press release from: Mordor Intelligence

Mordor Intelligence

Mordor Intelligence

On the occasion of World Diabetes Awareness Month, Mordor Intelligence reiterated its commitment to helping enterprises in the business of Diabetes Care Drugs by enabling them to make smart strategic decisions. The company has announced that it is offering a full access to its Intelligence Center on the Diabetes Care Drugs for FREE. With the successful launch of this Intelligence Center last month, Mordor is already ensuring that the benefits of this data reaches all possible enterprises in this space.

The data put together by Mordor Intelligence greatly strengthens the medical community's continuous research on understanding Diabetes and the drugs used in its treatment. This market intelligence data greatly benefits enterprises in making the right decisions, by helping foster a clear understanding of the various industry trends. The company is allowing enterprises FULL ACCESS to this exhaustive and precise data related to diabetes.

This limited time Free access can be set up here: https://www.mordorintelligence.com/free-trial/diabetes-care-market

Mordor's Intelligence Center on the Diabetes Care Drugs Market offers extensive and precise data spanning 15 segments under 4 categories, covering 25 countries from 5 regions. This data is additionally backed by the brand share information of 33 brands with an R&D pipeline. A key differentiator of this platform in comparison to similar services is the accuracy and timeliness of the data. This Intelligence Center is updated every quarter with significant changes reflecting real-time information. In addition, the platform is extremely user-friendly and offers a seamless, intuitive experience. In addition to Intelligence on Diabetes Care Drugs, Mordor also offers a comprehensive Intelligence Center on Diabetes Care Devices.

The coverage offered is as listed:

CATEGORIES & SEGMENTS

Insulin
Basal Insulin
Bolus Insulin
Human Insulin
Human Insulin Inhaled
Non-Insulin Injectables
Amylin Analogue
GLP-1 Agonist
Oral Antidiabetic Drugs
Alpha Glucosidase Inhibitors
Biguanides
Dopamine - B2 receptor agonist
DPP-4 Inhibitors
Meglitinide
SGLT-2 Inhibitors
Sulfonylureas
Combination Drugs
Insulin Combination
Oral Combination

REGIONS & COUNTRIES

Asia Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
South Korea
Thailand
Vietnam
Europe
France
Germany
Italy
Russia
Spain
United Kingdom
Latin America
Brazil
Mexico
North America
Canada
United States
Middle East
Egypt
Iran
Oman
Saudi Arabia
South Africa

BRANDS

Afrezza
Apidra
Basaglar
Bydureon
Byetta
Cycloset
Farxiga/Forxiga
Galvus
Generic
Humalog
Humulin
Insuman
Invokana
Janumet
Januvia
Jardiance
Lantus
Levemir
Lyxumia
Novolin/Human Insulin
Novolog/NovoRapid
NovoMix
Onglyza
Ryzodeg
Suglat
Symlin
Toujeo
Tradjenta
Tresiba
Trulicity
Victoza
Vipidia/Nesina
Xultophy

Mordor Intelligence, LLP. operates in the business of industry analysis & consulting, helping clients shape their strategic decisions. Founded in 2013, and fully revenue-funded, Mordor is based out of Hyderabad, India. The company offers custom market intelligence and advisory services along with syndicated reports to help customers gain the edge over the competition. Mordor caters to over 500 clients across the globe in various industries. (www.mordorintelligence.com)

MEDIA CONTACT

Name: Sameeksha Bansal
Email: sameeksha@mordorintelligence.com
Phone: +1-617-765-2493

Address- Mordor Intelligence
Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mordor Intelligence, LLP. Contributes to the Diabetes Awareness Month by Granting Free Access to Their Real-Time Exhaustive Research on Diabetes Care Drugs here

News-ID: 1377096 • Views:

More Releases from Mordor Intelligence

Ion Exchange Resin Market to Grow at 4.62% CAGR Through 2030, Led by DuPont, LANXESS, Mitsubishi Chemical Group, and Ecolab
Ion Exchange Resin Market to Grow at 4.62% CAGR Through 2030, Led by DuPont, LAN …
The Ion Exchange Resin Market is on a steady growth path, with its value projected to increase from USD 2.47 billion in 2025 to USD 3.10 billion by 2030, advancing at a CAGR of 4.62% during the study period of 2019-2030. This growth reflects rising demand across municipal and industrial water treatment, pharmaceuticals, food and beverage processing, and chemical applications. Asia Pacific stands out as the fastest-growing market, supported by rapid
Europe Plastic Waste Management Market to Reach USD 14.83 Billion by 2030, Driven by Recycling Infrastructure Expansion and Regulatory Support
Europe Plastic Waste Management Market to Reach USD 14.83 Billion by 2030, Drive …
Mordor Intelligence has published a new report on the Europe Plastic Waste Management Market, offering a comprehensive analysis of trends, growth drivers, and future projections. Overview of the Europe Plastic Waste Management Market The Europe plastic waste management market size reached USD 11.1 billion in 2025 and is forecast to climb to USD 14.83 billion by 2030, reflecting a steady 5.97% CAGR. These initiatives are helping improve the Europe
Airless Tires Market to Reach US 18.22 Billion by 2030, Fueled by EV Demand and Industrial Uptake - Mordor Intelligence
Airless Tires Market to Reach US 18.22 Billion by 2030, Fueled by EV Demand and …
Introduction The airless tires market is projected to grow from an estimated USD 14.74 billion in 2025 to USD 18.22 billion by 2030, according to the latest insights from Mordor Intelligence. This growth path reflects a compound annual growth rate (CAGR) of around 4.33 % over the forecast period. In this period, several shifts are contributing to the rising interest in non-pneumatic tire technology. Taller demands from electric vehicle
Automotive Semiconductor Market to Hit USD 142.87 Billion by 2030, Driven by Electrification, ADAS Expansion, and Software-Defined Vehicle Adoption
Automotive Semiconductor Market to Hit USD 142.87 Billion by 2030, Driven by Ele …
Mordor Intelligence has published a new report on the Automotive Semiconductor Market, offering a comprehensive analysis of trends, growth drivers, and future projections. Overview of the Automotive Semiconductor Market The automotive semiconductor market size reached USD 100.48 billion in 2025 and is projected to grow to USD 142.87 billion by 2030 at a 7.29% CAGR. Rising demand across devices and regions is boosting Automotive Semiconductor Market share. Growth is supported

All 5 Releases


More Releases for Insulin

Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin